Illumina 2026-02-06 Key facts: Illumina Q4 2025 revenue rises to $1.16B; 2026 growth forecasted - TradingView
FierceBiotech 2026-02-06 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
BioPharma Dive 2026-02-06 White House’s online service for drug sales debuts with limited impact on prices
FierceBiotech 2026-02-06 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study